Quavonlimab, CAS [[2254059-25-9]]

Produktübersicht

• Artikelname: Quavonlimab, CAS [[2254059-25-9]]
• Artikelnummer: TGM-T81329
• Hersteller Artikelnummer: T81329
• Alternativnummer: TGM-T81329-1MG,TGM-T81329-5MG,TGM-T81329-10MG,TGM-T81329-25MG,TGM-T81329-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MK-1308 , MK1308

Produktbeschreibung

Quavonlimab (MK-1308) is a novel human monoclonal antibody designed to selectively target and block the immune checkpoint molecule cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), investigation of quavonlimab in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab) has shown encouraging anti-tumor activity along with an acceptable safety profile,making it an interesting compound for the reasearches into advanced non-small cell lung cancer (NSCLC).

Produkteigenschaften

• Reinheit: 96.90%
• CAS Nummer: [2254059-25-9]
• Target-Kategorie: Others